UBS Group AG - EVOKE PHARMA INC ownership

Quarter-by-quarter ownership
UBS Group AG ownership history of EVOKE PHARMA INC
ValueSharesWeighting
Q1 2022$12,000
+500.0%
24,717
+591.8%
0.00%
Q4 2021$2,000
-33.3%
3,573
+55.1%
0.00%
Q3 2021$3,000
-87.5%
2,303
-86.7%
0.00%
Q2 2021$24,000
-58.6%
17,302
-45.5%
0.00%
Q1 2021$58,000
+1060.0%
31,757
+1709.5%
0.00%
Q4 2020$5,000
-89.4%
1,755
-82.5%
0.00%
Q3 2020$47,000
+2250.0%
10,057
+1496.3%
0.00%
Q2 2020$2,000630
+102.6%
0.00%
Q1 2020$0
-100.0%
311
-90.0%
0.00%
Q4 2019$5,000
+66.7%
3,118
+55.5%
0.00%
Q1 2019$3,000
-62.5%
2,005
-35.7%
0.00%
Q4 2018$8,000
-61.9%
3,118
-54.8%
0.00%
Q3 2018$21,000
+2000.0%
6,892
+1623.0%
0.00%
Q2 2018$1,000
-83.3%
400
-85.8%
0.00%
Q1 2018$6,000
-14.3%
2,826
-13.7%
0.00%
Q4 2017$7,0000.0%3,275
+46.2%
0.00%
Q3 2017$7,000
+16.7%
2,2400.0%0.00%
Q2 2017$6,000
-14.3%
2,240
-3.3%
0.00%
Q1 2017$7,000
+600.0%
2,316
+556.1%
0.00%
Q3 2016$1,000
-93.8%
353
-85.3%
0.00%
Q2 2016$16,000
+300.0%
2,394
+92.0%
0.00%
Q4 2015$4,000
+100.0%
1,247
+210.2%
0.00%
Q4 2014$2,0004020.00%
Other shareholders
EVOKE PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 87,925$48,0000.01%
Wambolt & Associates, LLC 32,000$18,0000.01%
Virtu Financial LLC 55,336$31,0000.00%
WELLS FARGO & COMPANY/MN 183$00.00%
NORTHERN TRUST CORP 42,121$23,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 3,828$2,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 210,102$117,0000.00%
STATE STREET CORP 72,800$41,0000.00%
MORGAN STANLEY 9,606$5,0000.00%
View complete list of EVOKE PHARMA INC shareholders